Linked Life Data

11680602

Source:http://linkedlifedata.com/resource/pubmed/id/11680602

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11680602rdf:typepubmed:Citationlld:pubmed
pubmed-article:11680602lifeskim:mentionsumls-concept:C0024523lld:lifeskim
pubmed-article:11680602lifeskim:mentionsumls-concept:C0400821lld:lifeskim
pubmed-article:11680602lifeskim:mentionsumls-concept:C0005390lld:lifeskim
pubmed-article:11680602lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:11680602lifeskim:mentionsumls-concept:C0401151lld:lifeskim
pubmed-article:11680602pubmed:issue10lld:pubmed
pubmed-article:11680602pubmed:dateCreated2001-10-26lld:pubmed
pubmed-article:11680602pubmed:abstractTextBile acid malabsorption (BAM) has been described in patients with collagenous colitis. There are no similar studies in lymphocytic colitis. The possibility that BAM might not necessarily be part of the microscopic colitis process and that both entities could simply be concomitant has not been evaluated. Our aim was to assess the frequency and severity of BAM in patients with microscopic colitis as well as in patients with previously unexplained functional chronic diarrhea. Likewise, we wanted to investigate the effect of cholestyramine on the induction and maintenance of remission of these conditions. A [75Se]HCAT abdominal retention test was performed in 26 patients with collagenous colitis, 25 with lymphocytic colitis, and 32 with previously unexplained functional chronic diarrhea. Patients with microscopic colitis who had BAM as well as a subgroup of eight collagenous colitis patients without BAM received treatment with cholestyramine. All patients with previously unexplained chronic diarrhea who had BAM were treated with cholestyramine. Twenty-two (43.1%) patients with microscopic colitis and 24 (75%) patients with previously unexplained functional chronic diarrhea presented with BAM. The frequency of BAM was higher in lymphocytic colitis than in collagenous colitis (60% vs 27%; P = 0.025). Cholestyramine induced clinical remission in 19 of 22 patients with microscopic colitis and BAM, none of eight patients with collagenous colitis without BAM, and all patients with previously unexplained chronic diarrhea and BAM. In conclusion, BAM seems to be common in patients with microscopic colitis-mainly in lymphocytic colitis-and in those with previously unexplained functional chronic diarrhea, suggesting that idiopathic BAM and microscopic colitis are often concomitant conditions. In this setting, cholestyramine seems to be highly effective in stopping diarrhea.lld:pubmed
pubmed-article:11680602pubmed:languageenglld:pubmed
pubmed-article:11680602pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11680602pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11680602pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11680602pubmed:statusMEDLINElld:pubmed
pubmed-article:11680602pubmed:monthOctlld:pubmed
pubmed-article:11680602pubmed:issn0163-2116lld:pubmed
pubmed-article:11680602pubmed:authorpubmed-author:VivesJ LJLlld:pubmed
pubmed-article:11680602pubmed:authorpubmed-author:Martín-CominJ...lld:pubmed
pubmed-article:11680602pubmed:authorpubmed-author:EsteveMMlld:pubmed
pubmed-article:11680602pubmed:authorpubmed-author:SalasAAlld:pubmed
pubmed-article:11680602pubmed:authorpubmed-author:Fernandez-Bañ...lld:pubmed
pubmed-article:11680602pubmed:authorpubmed-author:EspinosJ CJClld:pubmed
pubmed-article:11680602pubmed:authorpubmed-author:FornéT MTMlld:pubmed
pubmed-article:11680602pubmed:issnTypePrintlld:pubmed
pubmed-article:11680602pubmed:volume46lld:pubmed
pubmed-article:11680602pubmed:ownerNLMlld:pubmed
pubmed-article:11680602pubmed:authorsCompleteYlld:pubmed
pubmed-article:11680602pubmed:pagination2231-8lld:pubmed
pubmed-article:11680602pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:meshHeadingpubmed-meshheading:11680602...lld:pubmed
pubmed-article:11680602pubmed:year2001lld:pubmed
pubmed-article:11680602pubmed:articleTitleBile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea.lld:pubmed
pubmed-article:11680602pubmed:affiliationDepartment of Gastroenterology, Hospital Universitari Mútua de Terrassa, Spain.lld:pubmed
pubmed-article:11680602pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11680602pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11680602lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11680602lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11680602lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11680602lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11680602lld:pubmed